Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya
501 - 1000
💰 Post-IPO Equity on 2022-09
August 17
🏡 Remote – New York
⏰ Full Time
🟡 Mid-level
🟠 Senior